Tobin W Juvenal, Chief Commercial Officer at Castle Biosciences, sold CSTL on Nov 24, 2025
Data as of Oct 16
▼ SELL$49.9K1,301 shares at $38.39Tobin W Juvenal Chief Commercial OfficerCSTL Castle Biosciences Inc
- Traded
- Nov 24, 2025
- Disclosed
- Aug 6, 2026
- Filed
- 255 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CSTL since disclosure
+4.9%
after the sale
Similar stocks (XLV) since disclosure
+7.5%
XLV — its sector index fund
Change in closing price from Aug 6, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.